Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

SHPHF Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,522	3,779	3,829	5,682	4,604
Trading Asset Securities	110.58	589.02	962.99	109.3	332.68
Cash & Short-Term Investments	3,633	4,368	4,792	5,792	4,937
Cash Growth	-16.82%	-8.85%	-17.26%	17.32%	-6.24%
Accounts Receivable	593.93	397.82	522.25	779.07	389.82
Other Receivables	303.21	262.32	342.67	100.36	317.66
Receivables	1,305	1,045	977.61	1,094	820.92
Inventory	417	557.32	606.7	715.3	495.89
Other Current Assets	362.32	233.61	174.23	140.09	150.62
Total Current Assets	5,718	6,204	6,550	7,741	6,404
Property, Plant & Equipment	2,635	2,842	2,998	4,093	3,841
Long-Term Investments	818.04	1,004	907.34	972.53	1,267
Goodwill	1.85	1.85	1.85	14.17	12.31
Other Intangible Assets	598.76	655.52	594.1	445.8	310.92
Long-Term Deferred Tax Assets	32.13	31.77	96.77	303.46	269.45
Long-Term Deferred Charges	242.97	120.44	32.36	164.3	194.7
Other Long-Term Assets	485.39	359.63	393.46	393.84	400.82
Total Assets	10,532	11,535	12,141	14,496	13,044
Accounts Payable	273.18	220.61	205.78	118.91	106.2
Accrued Expenses	490.06	504.92	700.08	1,077	986.09
Short-Term Debt	-	-	25.8	30	283.29
Current Portion of Long-Term Debt	169.29	269.68	315.17	170	108.64
Current Portion of Leases	14.06	24.5	21.3	5.19	1.44
Current Income Taxes Payable	63.97	44.21	67.86	111.25	22.45
Current Unearned Revenue	110.02	143.05	175.92	214.11	197.11
Other Current Liabilities	2,190	2,900	1,021	775.11	737.87
Total Current Liabilities	3,310	4,107	2,533	2,502	2,443
Long-Term Debt	714.04	905.03	848.67	844.75	359.17
Long-Term Leases	45.38	51.98	79.94	31.46	2.51
Long-Term Unearned Revenue	313.31	163.28	135.81	82.34	64.74
Long-Term Deferred Tax Liabilities	5.26	70.32	99.04	222.39	225.69
Other Long-Term Liabilities	1,194	1,101	2,804	1,663	-
Total Liabilities	5,582	6,398	6,501	5,346	3,095
Common Stock	77.06	77.06	77.06	77.06	78.19
Additional Paid-In Capital	3,882	3,882	3,882	3,882	4,085
Retained Earnings	498.42	1,336	1,691	4,922	4,628
Treasury Stock	-54.11	-33.81	-	-	-
Comprehensive Income & Other	-31.42	-829.01	-913.86	-597.15	398.83
Total Common Equity	4,372	4,432	4,737	8,284	9,190
Minority Interest	577.05	704.89	902.83	865.92	758.38
Shareholders' Equity	4,949	5,137	5,640	9,150	9,949
Total Liabilities & Equity	10,532	11,535	12,141	14,496	13,044
Total Debt	942.77	1,251	1,291	1,081	755.05
Net Cash (Debt)	2,690	3,116	3,501	4,710	4,182
Net Cash Growth	-13.68%	-10.98%	-25.67%	12.64%	-20.30%
Net Cash Per Share	0.29	0.34	0.38	0.50	0.44
Filing Date Shares Outstanding	9,244	9,282	9,330	9,330	9,466
Total Common Shares Outstanding	9,244	9,282	9,330	9,330	9,466
Working Capital	2,407	2,097	4,017	5,240	3,961
Book Value Per Share	0.47	0.48	0.51	0.89	0.97
Tangible Book Value	3,772	3,775	4,141	7,824	8,867
Tangible Book Value Per Share	0.41	0.41	0.44	0.84	0.94
Buildings	-	3,539	3,596	2,956	2,763
Machinery	-	1,572	1,505	1,288	1,147
Construction In Progress	-	295.53	346.87	819.92	680.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.